Company profile
Electromed, Inc.
AMEX: ELMD · Healthcare · Medical - Devices
#405 of 1,422 Healthcare companies by revenue63rd-percentile growth
EA Score
80B+FH 91DQ 69GM 75SS 70
v0.1 · 65/100 weight · provisional
↑ growth stability, Altman-Z · ↓ filing timeliness, revenue growth (YoY)
Methodology →Revenue TTM
$71.8M
Rev growth YoY (TTM)
+16.8%
Net income (FY)
$7.5M
Employees
179
as of 2026-08-12
Market cap
$351.0M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$64.0M$64.0M2025
Net income$7.5M$7.5M2025
Operating income$9.7M$9.7M2025
Total assets$53.8M$53.8M2025
Liabilities$10.6M$10.6M2025
Equity$43.2M$43.2M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Electromed, Inc.’s revenue?
Electromed, Inc. booked $64.0M in FY2025 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a 11.8% net margin.
Peers · Healthcare
Enanta Pharmaceuticals, Inc.55CCosmos Health Inc.55CConcord Medical Services Holdings Limited59CNuvation Bio Inc.49DDIH Holding US, Inc.——Sorrento Therapeutics, Inc.——Key facts
CEOJames L. Cunniff
SectorHealthcare
IndustryMedical - Devices
HeadquartersNew Prague, MN
ExchangeAMEX: ELMD
Employees179
IPO date2010-08-13
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.